Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17509 | 532 | 48.9 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MIR 34A | Author keyword | 60 | 50% | 16% | 87 |
| 2 | MICRORNA 34A | Author keyword | 15 | 59% | 3% | 17 |
| 3 | MIR 34 | Author keyword | 15 | 54% | 4% | 19 |
| 4 | MIR 34C | Author keyword | 12 | 54% | 3% | 15 |
| 5 | MIR 34C 5P | Author keyword | 6 | 80% | 1% | 4 |
| 6 | MIR34A | Author keyword | 4 | 75% | 1% | 3 |
| 7 | SONGPA RD | Address | 4 | 75% | 1% | 3 |
| 8 | MIR 34 FAMILY | Author keyword | 3 | 100% | 1% | 3 |
| 9 | MIR 34B C | Author keyword | 3 | 35% | 1% | 7 |
| 10 | MIR 34B | Author keyword | 3 | 42% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MIR 34A | 60 | 50% | 16% | 87 | Search MIR+34A | Search MIR+34A |
| 2 | MICRORNA 34A | 15 | 59% | 3% | 17 | Search MICRORNA+34A | Search MICRORNA+34A |
| 3 | MIR 34 | 15 | 54% | 4% | 19 | Search MIR+34 | Search MIR+34 |
| 4 | MIR 34C | 12 | 54% | 3% | 15 | Search MIR+34C | Search MIR+34C |
| 5 | MIR 34C 5P | 6 | 80% | 1% | 4 | Search MIR+34C+5P | Search MIR+34C+5P |
| 6 | MIR34A | 4 | 75% | 1% | 3 | Search MIR34A | Search MIR34A |
| 7 | MIR 34 FAMILY | 3 | 100% | 1% | 3 | Search MIR+34+FAMILY | Search MIR+34+FAMILY |
| 8 | MIR 34B C | 3 | 35% | 1% | 7 | Search MIR+34B+C | Search MIR+34B+C |
| 9 | MIR 34B | 3 | 42% | 1% | 5 | Search MIR+34B | Search MIR+34B |
| 10 | MICRORNA 34 | 2 | 44% | 1% | 4 | Search MICRORNA+34 | Search MICRORNA+34 |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | MIR 34A | 33 | 35% | 14% | 77 |
| 2 | TUMOR SUPPRESSOR NETWORK | 13 | 37% | 5% | 29 |
| 3 | MICRORNA 34A | 7 | 57% | 2% | 8 |
| 4 | MIR 34 FAMILY | 5 | 43% | 2% | 9 |
| 5 | MIR 34A CONTRIBUTES | 3 | 50% | 1% | 4 |
| 6 | CANCER PC3 CELLS | 2 | 67% | 0% | 2 |
| 7 | IDENTIFIES MIR 34A | 2 | 50% | 1% | 3 |
| 8 | MIR 34 | 2 | 40% | 1% | 4 |
| 9 | MICRORNA 34B C | 2 | 43% | 1% | 3 |
| 10 | P53 INDUCIBLE MICRORNAS | 1 | 21% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues | 2015 | 5 | 80 | 30% |
| miR-34: from bench to bedside | 2014 | 21 | 97 | 41% |
| The miR-34 family in cancer and apoptosis | 2010 | 389 | 62 | 29% |
| MicroRNA-34a: a potential therapeutic target in human cancer | 2014 | 7 | 82 | 46% |
| MicroRNAs in the p53 network: micromanagement of tumour suppression | 2012 | 133 | 172 | 17% |
| The p53/miR-34 axis in development and disease | 2014 | 11 | 183 | 34% |
| Role of MicroRNA in Response to Ionizing Radiations: Evidences and Potential Impact on Clinical Practice for Radiotherapy | 2014 | 6 | 82 | 45% |
| Genistein Inhibits Cell Growth and Induces Apoptosis Through Up-regulation of miR-34a in Pancreatic Cancer Cells | 2012 | 24 | 35 | 40% |
| MicroRNAs and DNA damage response Implications for cancer therapy | 2013 | 24 | 146 | 23% |
| MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review | 2014 | 2 | 142 | 44% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SONGPA RD | 4 | 75% | 0.6% | 3 |
| 2 | MOL BIOL PROSTATE CANC GRP | 2 | 67% | 0.4% | 2 |
| 3 | EPIGENET CELL CYCLING SIGNALING | 1 | 100% | 0.4% | 2 |
| 4 | MOL TARGETED DRUG | 1 | 19% | 0.9% | 5 |
| 5 | KOREA SKIN CLIN SCI | 1 | 18% | 0.9% | 5 |
| 6 | CARCINOGENESIS INVAS | 1 | 27% | 0.6% | 3 |
| 7 | SPACE RADIOBIOL | 1 | 16% | 0.8% | 4 |
| 8 | ANIM BIOTECHNOLAGR MINIST | 1 | 50% | 0.2% | 1 |
| 9 | CORNELL STEM CELL PROGRAM | 1 | 50% | 0.2% | 1 |
| 10 | FDN BANCO BILBAO VIZCAYA F BBVA | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000273501 | MICRORNA//MIR 21//MICRORNAS |
| 2 | 0.0000246555 | NEUROTRAUMA VARIAT REGENERAT//TIANTAN HOSP//OTORHINOLARYNGOL MAXILLO IAL ONCOL |
| 3 | 0.0000210436 | DICER//DROSHA//MICROPROCESSOR COMPLEX |
| 4 | 0.0000116100 | GW182//DROSHA//ARGONAUTE |
| 5 | 0.0000114737 | MIR 196A2//RS2910164//RS11614913 |
| 6 | 0.0000098297 | MIR 122//MICRORNA 122//MIR 224 |
| 7 | 0.0000098086 | MIR 210//MICRORNA 210//C19MC |
| 8 | 0.0000075856 | MIR 155//MIR 146A//MIRNA 155 |
| 9 | 0.0000070427 | LIN28//LIN28B//LIN28A |
| 10 | 0.0000067014 | MUTANT P53//GAIN OF FUNCTION//CANC THER EUT S |